Eiji Mitate

Dr. Eiji Mitate

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
EMEiji Mitate
Eiji Mitate
SKS Kawano
S Kawano
YNY Nakao
Y Nakao
YGY Goto
Y Goto
IKI Kobayashi
I Kobayashi
SNS Nakamura
S Nakamura

17 September 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
EMEiji Mitate
Eiji Mitate
SKShintaro Kawano
Shintaro Kawano
TKTamotsu Kiyoshima
Tamotsu Kiyoshima
TKToshiyuki Kawazu
Toshiyuki Kawazu
TCToru Chikui
Toru Chikui
SNSeiji Nakamura
Seiji Nakamura
Background: Squamous cell carcinoma (SCC) as the malignant component of carcinoma ex pleomorphic adenoma (CXPA) occurring in upper lip is rare. Case report: A 55-year-old male patient presented with an asymptomatic mass of the upper lip that had noticed 8 years previously. The mass was clinically suspected to be a benign salivary gland tumor based on palpation and magnetic resonance imaging findings. A needle biopsy was then carried out, and the pathological diagnosis was pleomorphic adenoma. The tumor was removed under general anesthesia. Histopathological examination revealed well-demarcated tumor tissues showing typical histologic features of pleomorphic adenoma. However, SCC tissue with several mitotic figures was found in the central area of the tumor tissue. The tumor was finally diagnosed as CXPA. There was no evidence of recurrence or metastasis 6 years postoperatively. Conclusion: This is the first report of CXPA of the upper lip with an unusual malignant component of SCC.

2 August 2022 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
EMEiji Mitate
Eiji Mitate
KIKirin Inoue
Kirin Inoue
RSRetsushi Sato
Retsushi Sato
YSYouichi Shimomoto
Youichi Shimomoto
SOSeigo Ohba
Seigo Ohba
IAIzumi Asahina
Izumi Asahina
Background: We aimed to develop an artificial intelligence (AI)-assisted oral cytology method, similar to cervical cytology. We focused on the detection of cell nuclei because the ratio of cell nuclei to cytoplasm increases with increasing cell malignancy. As an initial step in the development of AI-assisted cytology, we investigated two methods for the automatic detection of cell nuclei in blue-stained cells in cytopreparation images. Methods: We evaluated the usefulness of the sliding window method (SWM) and mask region-based convolutional neural network (Mask-RCNN) in identifying the cell nuclei in oral cytopreparation images. Thirty cases of liquid-based oral cytology were analyzed. First, we performed the SWM by dividing each image into 96 × 96 pixels. Overall, 591 images with or without blue-stained cell nuclei were prepared as the training data and 197 as the test data (total: 1,576 images). Next, we performed the Mask-RCNN by preparing 130 images of Class II and III lesions and creating mask images showing cell regions based on these images. Results: Using the SWM method, the highest detection rate for blue-stained cells in the evaluation group was 0.9314. For Mask-RCNN, 37 cell nuclei were identified, and 1 cell nucleus was identified as a non-nucleus after 40 epochs (error rate:0.027). Conclusions: Mask-RCNN is more accurate than SWM in identifying the cell nuclei. If the blue-stained cell nuclei can be correctly identified automatically, the entire cell morphology can be grasped faster, and the diagnostic performance of cytology can be improved.

27 August 2015 in Case Reports in Emergency Medicine
Verified
Journal Article
Open access
PDF file
EMEiji Mitate
Eiji Mitate
KKKensuke Kubota
Kensuke Kubota
KUKenji Ueki
Kenji Ueki
RIRumi Inoue
Rumi Inoue
RIRyosuke Inoue
Ryosuke Inoue
SNSeiji Nakamura
Seiji Nakamura
Communication is a serious problem for patients with ventilator-dependent tetraplegia. A 73-year-old man was presented at the emergency room in cardiopulmonary arrest after falling from a height of 2 m. After successful resuscitation, fractures of the cervical spine and cervical spinal cord injury were found. Due to paralysis of the respiratory muscles, a mechanical ventilator with a tracheostomy tube was required. First, a cuffed tracheostomy tube and a speaking tracheostomy tube were inserted, and humidified oxygen was introduced via the suction line. Using these tubes, the patient could produce speech sounds, but use was limited to 10 min due to discomfort. Second, a mouthstick stylus, fixed on a mouthpiece that fits over the maxillary teeth, was used. The patient used both a communication board and a touch screen device with this mouthstick stylus. The speaking tracheostomy tube and mouthstick stylus greatly improved his ability to communicate.

1 January 2006 in Japanese Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
SKShintaro Kawano
Shintaro Kawano
KOKazunari Oobu
Kazunari Oobu
KMKazuhide Matsunaga
Kazuhide Matsunaga
EKEiko Kawano
Eiko Kawano
EMEiji Mitate
Eiji Mitate
SNSeiji Nakamura
Seiji Nakamura

5 April 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
SKShintaro Kawano
Shintaro Kawano
YZYanqun Zheng
Yanqun Zheng
KOKazunari Oobu
Kazunari Oobu
RMRyota Matsubara
Ryota Matsubara
YGYuichi Goto
Yuichi Goto
SNSeiji Nakamura
Seiji Nakamura
The administration of pre-operative chemotherapy with S-1 and concurrent radiotherapy at a total dose of 30 Gy was clinicopathologically evaluated as a treatment for locally advanced oral squamous cell carcinoma (OSCC) in the present study. The participants comprised 81 patients with OSCC, consisting of 29 patients with stage II disease, 12 patients with stage III disease and 40 patients with stage IV disease. All patients received a total radiation dose of 30 Gy in daily fractions of 2 Gy, 5 times a week, for 3 weeks, and the patients were concurrently administered S-1 at a dose of 80–120 mg, twice daily, over 4 consecutive weeks. Radical surgery was performed in all cases at 2–6 weeks subsequent to the end of pre-operative chemoradiotherapy. The most common adverse event was oropharyngeal mucositis, but this was transient in all patients. No severe hematological or non-hematological toxicities were observed. The clinical and histopathological response rates were 70.4 and 75.3%, respectively. Post-operatively, local failure developed in 6 patients (7.4%) and neck failure developed in 2 patients (2.5%). Distant metastases were found in 7 patients (8.6%). The overall survival rate, disease-specific survival rate and locoregional control rate at 5 years were 87.7, 89.9 and 90.6%, respectively. Locoregional recurrence occurred more frequently in patients that demonstrated a poor histopathological response compared with patients that demonstrated a good response (P<0.01). These results indicate that pre-operative S-1 chemotherapy with radiotherapy at a total dose of 30 Gy is feasible and effective for patients with locally advanced OSCC, and that little or no histopathological response may be a risk factor for locoregional recurrence in this treatment.